AC
SBC

Aristeia Capital’s SBC Medical Group SBC Stock Holding History

Aristeia Capital’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-819,950
Closed -$8.56M – 290
2023
Q1 		$8.56M Buy
819,950
+639,950
+356% +$6.61M 0.2% 112
2022
Q4 		$1.84M Hold
180,000
– – 0.04% 301
2022
Q3 		$1.8M Buy
+180,000
New +$1.8M 0.03% 382

Other funds holding SBC

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return

Aristeia Capital's SBC Position: Q2 2023 in Review

Aristeia Capital sold out of SBC Medical Group (SBC) in Q2 2023, closing a stake of 819,950 shares — an estimated $8.56M sold.

Aristeia Capital first reported a position in SBC in Q3 2022 and held it in 3 quarters. The position peaked at $8.56M in Q1 2023. 13 funds tracked by Wall St. Rank hold SBC as of Q2 2023.

  • Aristeia Capital reported no remaining SBC Medical Group position as of Q2 2023 after selling out during the quarter.
  • Aristeia Capital sold 819,950 SBC Medical Group shares in Q2 2023, an estimated $8.56M.
  • Aristeia Capital first reported a position in SBC Medical Group in Q3 2022 and held it in 3 quarters.
  • Aristeia Capital's SBC Medical Group position peaked at $8.56M in Q1 2023.
  • 13 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2023.

Based on Aristeia Capital's 13F filing for Q2 2023, filed 14 Aug 2023.